Advertisement
Advertisement
VERA
Vera Therapeutics, Inc. Class A Common Stock
37.17
USDSponsored
+0.18
+0.49%
Jul 21, 15:59 UTC -4
Closed
After-Market
36.93
-0.24
-0.65%
VERA Earnings Reports
Positive Surprise Ratio
VERA beat 6 of 21 last estimates.
29%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$1.60
Implied change from Q1 26 (Revenue/ EPS)
--
/-5.33%
Implied change from Q2 25 (Revenue/ EPS)
--
/+33.33%
Vera Therapeutics, Inc. Class A Common Stock earnings per share and revenue
On May 07, 2026, VERA reported earnings of -1.69 USD per share (EPS) for Q1 26, missing the estimate of -1.35 USD, resulting in a -24.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of -1.60 USD, with revenue projected to reach -- USD, implying an decrease of -5.33% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jul 09, 2026 For Q2 26
Estimate
-$0.73
Actual
-$0.81
Surprise
-10.78%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Vera Therapeutics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Vera Therapeutics, Inc. Class A Common Stock reported EPS of -$1.69, missing estimates by -24.86%, and revenue of $0.00, 0% as expectations.
How did the market react to Vera Therapeutics, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved down -1.95%, changed from $36.59 before the earnings release to $35.88 the day after.
When is Vera Therapeutics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Vera Therapeutics, Inc. Class A Common Stock's next earnings report?
Based on 11
analysts, Vera Therapeutics, Inc. Class A Common Stock is expected to report EPS of -$1.60 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement